IRIS UniCatt

Metafuni, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.511
AS - Asia 2.422
EU - Europa 2.358
SA - Sud America 536
AF - Africa 77
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.909
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.423
SG - Singapore 1.180
CN - Cina 669
DE - Germania 608
SE - Svezia 452
BR - Brasile 439
IT - Italia 436
FR - Francia 199
GB - Regno Unito 148
IE - Irlanda 120
VN - Vietnam 110
IN - India 107
FI - Finlandia 90
ID - Indonesia 87
UA - Ucraina 76
RU - Federazione Russa 63
KR - Corea 46
CA - Canada 42
HK - Hong Kong 33
MX - Messico 32
AR - Argentina 31
TR - Turchia 28
BD - Bangladesh 26
NL - Olanda 25
PL - Polonia 25
AT - Austria 23
IQ - Iraq 23
CI - Costa d'Avorio 21
ZA - Sudafrica 21
BE - Belgio 20
JP - Giappone 19
CO - Colombia 16
CZ - Repubblica Ceca 16
EC - Ecuador 15
ES - Italia 12
SA - Arabia Saudita 12
UZ - Uzbekistan 10
VE - Venezuela 10
UY - Uruguay 9
KE - Kenya 8
MA - Marocco 8
PY - Paraguay 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
DZ - Algeria 6
PK - Pakistan 6
CH - Svizzera 5
JO - Giordania 5
LT - Lituania 5
PH - Filippine 5
RO - Romania 5
AM - Armenia 4
AZ - Azerbaigian 4
EG - Egitto 4
IL - Israele 4
IR - Iran 4
LV - Lettonia 4
NP - Nepal 4
SN - Senegal 4
AU - Australia 3
JM - Giamaica 3
LB - Libano 3
PT - Portogallo 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
TN - Tunisia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
Totale 7.902
Salva come PNG Salva come JPEG
Città #
Singapore 582
Chandler 402
Ashburn 244
Beijing 141
Hefei 122
Dublin 118
Rome 99
Los Angeles 97
Jakarta 81
Munich 81
New York 79
Dallas 69
Milan 69
San Mateo 68
Frankfurt am Main 62
Jacksonville 62
Houston 57
Chicago 54
Hyderabad 53
Florence 49
Nanjing 49
Dearborn 48
Seoul 44
Ann Arbor 42
Marseille 42
São Paulo 42
Wilmington 38
Helsinki 37
Moscow 37
The Dalles 37
Kent 36
Boston 34
Ho Chi Minh City 34
Lancaster 34
Princeton 33
Hong Kong 31
Cattolica 30
Hanoi 30
Nürnberg 29
Seattle 27
Bremen 26
Santa Clara 25
Nuremberg 24
Buffalo 23
Lappeenranta 23
London 22
Nanchang 22
Abidjan 21
Brussels 20
Tokyo 19
Toronto 19
Rio de Janeiro 18
Stockholm 17
Tianjin 17
Poplar 16
Warsaw 16
Izmir 15
Woodbridge 15
Atlanta 14
Belo Horizonte 14
Denver 14
Guangzhou 14
Turku 14
Washington 14
Boardman 13
Brooklyn 13
Fairfield 13
Johannesburg 13
Lawrence 13
Orem 13
Phoenix 13
Pune 13
Brno 12
Augusta 11
Curitiba 11
Norwalk 11
San Francisco 11
Shanghai 11
Vienna 11
Düsseldorf 10
Mexico City 10
Portsmouth 10
Redwood City 10
Bexley 9
Charlotte 9
Dhaka 9
Lauterbourg 9
Montreal 9
Porto Alegre 9
Tashkent 9
Amsterdam 8
Arezzo 8
Baghdad 8
Brasília 8
Campinas 8
Chennai 8
Montevideo 8
Mountain View 8
Naples 8
Falkenstein 7
Totale 4.129
Salva come PNG Salva come JPEG
Nome #
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 215
Correlation between paraproteinaemia and viral reactivation after allo-SCT 185
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 175
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 164
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 159
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 158
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 144
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
Hyperleukocytosis and leukostasis: management of a medical emergency 138
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 136
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 131
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 131
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 131
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 124
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 123
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 120
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 119
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 119
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 118
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 117
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 113
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 113
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 108
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 106
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 106
Changes in protein serum levels during stem cell transplantation 104
Unrelated cord blood transplantation and post-transplant cyclophosphamide 103
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 103
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 102
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 101
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 99
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 99
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 97
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 97
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 96
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 94
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 94
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 93
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 93
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 92
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 88
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 86
Unrelated cord blood transplantation and post-transplant cyclophosphamide 84
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 83
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 82
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 82
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 82
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review 81
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 80
MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings 80
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 80
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 79
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 78
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 y with Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study 77
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 77
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 77
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 76
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 76
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 75
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 74
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 74
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients 74
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 72
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 72
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 72
Reducing infectious complications after allogeneic stem cell transplant 68
Second haploidentical stem cell transplantation for primary graft failure 68
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 64
Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis 64
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 64
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants 63
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience 62
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center 60
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 59
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 59
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation 57
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 57
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 56
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 55
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 55
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 52
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 52
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience 52
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 49
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 43
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 31
Saprochaete clavata infection in immunosuppressed patients: Systematic review of cases and report of the first oral manifestation, focusing on differential diagnosis 23
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 13
Totale 8.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.483
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 17 15 12 31 10 72 7
2021/2022488 34 14 29 24 43 12 9 72 19 45 98 89
2022/20231.216 188 159 72 185 85 135 88 84 102 51 54 13
2023/2024776 29 156 45 60 21 94 65 43 17 56 85 105
2024/20251.997 47 52 127 101 170 65 89 85 215 218 472 356
2025/20262.325 616 146 319 471 627 146 0 0 0 0 0 0
Totale 8.047